5th Central European Biomedical Congress
Organiser: Other
Attendance type(s): In Person
Event Dates: 29 May—1 Jun 2023
- 29/05/2023
- 01/06/2023
Registration Deadline: 15 May 2023
Dear Colleagues,
On behalf of the Scientific and Organizing Committees of the Central European Biomedical Congress (CEBC), it is our great pleasure to invite you to join the 5th CEBC held from May 29 till June 1, 2023, in Krakow, Poland.
This Congress is jointly organized by the Maj Institute of Pharmacology Polish Academy of Sciences and the Faculty of Medicine, Jagiellonian University Medical College.
5th CEBC will be held under the title: “Future trends in health interventions”.
Plenary speakers who have already confirmed their participation:
- Prof. Gustavo Turecki PhD, MD
- Douglas Hospital Research Centre, McGill Group for Suicide Studies, Montreal, Quebec, Canada
- Prof. Véronique Deroche-Gamonet PhD, HDR
- Université de Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France
- Prof. Stefan Chłopicki, PhD, MD
- Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland
- Prof. Johannes Kornhuber, PhD, MD,
- Department of Psychiatry and Psychotherapy, Friedrich-Alexander-Universität Erlangen-Nürnberg University Hospital, Erlangen, Germany
- Prof. Kathryn A. Cunningham, PhD, MD
- The University of Texas Medical Branch, Galveston, USA
- Prof. Stéphane Oliet, PhD
Bordeaux Neurocampus, University de Bordeaux, France
- ️SESSIONS:Blood-brain barrier dysfunction in CNS disorders
- Nanotheranostics and CNS disorders
- Mass spectrometry in medical sciences
- Immunodiagnostics & immunotherapy
- Neurodegenerative and psychiatric disorders
- Sphingolipids in health and brain diseases
- Novel rapid-acting antidepressants
- A novel approach for the treatment of the CNS pathologies
- Chaperons in Gaucher’s disease
- Digital medicine – beyond diagnostics
- Medical biotechnology in disease modelling
- Tracking brain projections and cell signaling involved in neuroadaptations triggered by cocaine, stress, or neurodegeneration
- Innovative nanocarriers and treatment modalities in antitumor therapy
- Future therapies with psychedelics
- Duchenne muscular dystrophy – mechanisms and possible treatments
- Magnificent Seven: on the role of the 5-HT7R receptor in the brain
- Young scientific investigators’ session
Contact Details
Name: Viktoriia Popadynets
Phone: 48504342426
Email: viktoriia99p@gmail.com